The global Pain Relief Gel Market size was estimated at USD 10.4 billion in 2023 and is projected to reach USD 15.3 billion in 2030 at a CAGR of 5.2% during the forecast period 2023-2030.

Chronic pain conditions, which include ailments such as arthritis, back pain, and musculoskeletal disorders, are widely prevalent on a global scale. The escalating number of individuals in pursuit of alleviation from the persistent agony that accompanies chronic pain syndromes has resulted in a parallel increase in the demand for pain relief gels, owing to their potential to mitigate the discomfort associated with these conditions.

Get Free Sample Report@ https://www.delvens.com/get-free-sample/pain-relief-gel-market

The current outbreak of COVID-19 is expected to have a substantial impact on the development and progression of the global topical pain relief market. The unprecedented occurrence of the COVID-19 pandemic has placed immense strain on healthcare systems worldwide, resulting in a significant reduction in the number of patient visits to a vast number of clinics and pain services during this period of uncertainty and instability.

Key Findings:

On the basis of therapeutic class, the segment of non-opioids, which is characterized as drugs that do not exhibit morphine-like effects, is identified as the primary source of revenue and is estimated to experience significant growth during the period of projection.

On the basis of distribution channel, the market encompasses a variety of entities such as pharmacies and drug stores, e-commerce platforms, as well as retail and grocery stores, can be effectively classified into three distinct categories based on their respective operational characteristics. 

The Fully Graphic E-paper display type is projected to experience rapid growth during the forecast period. These displays, with their paper-like appearance and low power consumption, outperform traditional LCD and LED technologies. They provide superior performance compared to segmented or partial graphic e-paper displays and are capable of showing detailed graphics, animations, and high-resolution images.

Recent Developments

·        In January 2023, Deccan Healthcare, a pioneering nutraceutical and cosmeceutical products company, has recently unveiled the QuitPain instant pain relieving ayurvedic gel in Hyderabad. This highly efficacious gel, which is a proprietary blend of Deccan Healthcare Ltd., has been specially crafted to cater to those seeking easy-to-use ayurvedic pain relief solutions for the alleviation of a myriad of aches and pains.
 

·        In December 2022, Manx Healthcare, a prominent pharmaceutical company, recently introduced a novel product into the market, namely Reliviate Aches and Joint Pain Relief 0.5% w/w Gel. This innovative gel, which has been meticulously formulated, is specifically designed to alleviate aches and joint pain, thus providing an efficacious solution for individuals suffering from such debilitating conditions.

Competitive Landscape

·        Nestle S.A.

·        Sun Pharmaceutical Industries Ltd.

·        AdvaCare Pharma

·        Topical BioMedics, Inc.

·        Reckitt Benckiser Group Plc.

·        Novartis AG

·        Pfizer Inc. and more.

For More Inquiry@ https://www.delvens.com/Inquire-before-buying/pain-relief-gel-market

North America to Dominate the Market

·        The North American region has emerged as the predominant market for pain relief gel, primarily owing to the escalating aging population in this region. Additionally, the burgeoning investment in healthcare infrastructure has further contributed to the substantial growth of this market.
 

·        It is anticipated that the region encompassing Asia and the Pacific shall undergo a noteworthy escalation in terms of growth.

The Pain Relief Gel Market Segmentation:

Based on By Therapeutic Class

·        Non-opioids

·        Opioids

Based on the Type

·        Prescription pain relief

·        Over-the-counter pain relief

Based on the Distribution Channel

·        Pharmacies & drug stores

·        E-Commerce

·        Retail & grocery stores

Based on region:

·        Asia Pacific

·        North America

·        Europe

·        South America

·        Middle East & Africa

Get Complete Info@ https://www.delvens.com/report/pain-relief-gel-market

Frequently Asked Questions

·        What are the years considered to study Pain Relief Gel Market intelligence report?

·        What is the compound annual growth rate (CAGR) of the Pain Relief Gel Market?

·        Which region holds the largest market share in Pain Relief Gel Market?

·        Which region is the fastest growing in Pain Relief Gel Market?

·        Who are the major players in Pain Relief Gel Market?

In addition to the market data for the Pain Relief Gel Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.

More Related Reports:
Mutant Metastatic Colorectal Cancer (mCRC) Market
Biosimilars Market

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact us:

Unit No. 01, 3rd Floor, Plot No. 56, Block B

Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN

+44 20 3290 6466

+0120- 4903958

sales@delvens.com